Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1501 Articles

Jon C. Ogg | Jan 7, 2020 at 2:58 PM EST

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.

Jon C. Ogg | Jan 6, 2020 at 12:45 PM EST

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Here is a review and preview of how the model for Dow Jones industrial average could point to a baseline…

Jon C. Ogg | Jan 2, 2020 at 4:51 PM EST

Is Pfizer Raising Drug Prices Too Much in 2020?

Ahead of election years, the cost and future of health care has become one of the top debates for better…

Chris Lange | Jan 2, 2020 at 10:25 AM EST

The Top Biopharma Events to Watch in 2020

Here, 24/7 Wall St. presents a calendar of a few of the biggest clinical trial and FDA updates to watch…

Paul Ausick | Dec 31, 2019 at 6:55 AM EST

5 Top (and Bottom) Dow Performers in 2019

Here's a look at the five best- and five worst-performing stocks among the Dow Jones industrial average this past year.

Chris Lange | Dec 26, 2019 at 8:55 AM EST

Big Pharma Short Sellers Get Selective

The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Dec 26, 2019 at 6:40 AM EST

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Microsoft, Pfizer and Intel above all other Dow stocks.

Chris Lange | Dec 23, 2019 at 11:00 AM EST

The Top Biopharma Calendar Events to Watch Going Into 2020

Here, 24/7 Wall St. has included a calendar of a few of the biggest clinical trial and FDA updates to…

Jon C. Ogg | Dec 13, 2019 at 12:25 PM EST

Meet the Preliminary 2020 Dogs of the Dow

One theme that investors love in good times and in bad is dividend investing. One strategy that has been around…

Chris Lange | Dec 11, 2019 at 9:45 AM EST

Big Pharma Short Sellers Grow More Selective

The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Dec 11, 2019 at 7:10 AM EST

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Apple, Microsoft and Intel above all other Dow stocks.

Chris Lange | Nov 27, 2019 at 9:00 AM EST

Big Pharma Short Sellers Hike Their Bets

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Nov 18, 2019 at 10:50 AM EST

How Dow 28,000 Can Rapidly Become Dow 30,000 and Even Higher in 2020

Despite the never-ending election cycle, there actually is a clear path for the Dow to hit 30,000 as soon as…

Chris Lange | Nov 12, 2019 at 8:50 AM EST

Big Pharma Scares Off Short Sellers

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Nov 12, 2019 at 7:05 AM EST

The 5 Most Shorted Dow Stocks

As of the most recently reported settlement date, short sellers still favored Microsoft, Intel and Pfizer above all other Dow…

1 … 25 26 27 28 29 … 101

Pfizer : PFE

All Pfizer Articles

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Is Pfizer Raising Drug Prices Too Much in 2020?

The Top Biopharma Events to Watch in 2020

5 Top (and Bottom) Dow Performers in 2019

Big Pharma Short Sellers Get Selective

The 6 Most Shorted Dow Stocks

The Top Biopharma Calendar Events to Watch Going Into 2020

Meet the Preliminary 2020 Dogs of the Dow

Big Pharma Short Sellers Grow More Selective

The 6 Most Shorted Dow Stocks

Big Pharma Short Sellers Hike Their Bets

How Dow 28,000 Can Rapidly Become Dow 30,000 and Even Higher in 2020

Big Pharma Scares Off Short Sellers

The 5 Most Shorted Dow Stocks

Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

Are DRAM Stocks Too Hot To Handle Yet or Is This Just the Start of a Bigger Move?

The Commercial Space Economy Just Crossed $500 Billion in Backlog and These 3 ETFs Own the Pure Play Names

FTEC vs. VGT: Same Tech Bet, So Which Fund Costs You Less?

Ford Is Calling Its 'Gray Beard' Engineers Back to Work. At 68, He Feared the Paycheck Would Cut His Social Security. Past Full Retirement Age, It Doesn't.

IRMAA Has Five Income Brackets. Crossing Just the First Costs You About $900 a Year.

Are DRAM Stocks Too Hot To Handle Yet or Is This Just the Start of a Bigger Move?

The Commercial Space Economy Just Crossed $500 Billion in Backlog and These 3 ETFs Own the Pure Play Names

Pfizer : PFE

All Pfizer Articles

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Is Pfizer Raising Drug Prices Too Much in 2020?

The Top Biopharma Events to Watch in 2020

5 Top (and Bottom) Dow Performers in 2019

Big Pharma Short Sellers Get Selective

The 6 Most Shorted Dow Stocks

The Top Biopharma Calendar Events to Watch Going Into 2020

Meet the Preliminary 2020 Dogs of the Dow

Big Pharma Short Sellers Grow More Selective

The 6 Most Shorted Dow Stocks

Big Pharma Short Sellers Hike Their Bets

How Dow 28,000 Can Rapidly Become Dow 30,000 and Even Higher in 2020

Big Pharma Scares Off Short Sellers

The 5 Most Shorted Dow Stocks

Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

Are DRAM Stocks Too Hot To Handle Yet or Is This Just the Start of a Bigger Move?

The Commercial Space Economy Just Crossed $500 Billion in Backlog and These 3 ETFs Own the Pure Play Names

FTEC vs. VGT: Same Tech Bet, So Which Fund Costs You Less?

Featured Reads

Ford Is Calling Its 'Gray Beard' Engineers Back to Work. At 68, He Feared the Paycheck Would Cut His Social Security. Past Full Retirement Age, It Doesn't.

IRMAA Has Five Income Brackets. Crossing Just the First Costs You About $900 a Year.